For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Search Posts
Op-Eds
Europe’s Continued Hostility to GM Crops Runs Afoul of Science, WTO
France, Germany, and the United Kingdom may have new leaders who bring the promise overall of better trans-Atlantic relations, but when it comes to the…
News Release
FDA Gives a Thumbs Up to Cloned Milk and Meat
Op-Eds
Vaccine Vindication
The vaccine preservative Thimerosal is not linked with autism, a new study reports. The data also suggest that the dilettante "scientist" Robert F. Kennedy,…
Newsletter
CEI Daily Update
Issues in the News 1. ENVIRONMENT Activists fight a gold mining project in the Romanian village of Rosia Montana. CEI Expert…
Newsletter
CEI Daily Update
Issues in the News 1. LEGAL The American Tort Reform Foundation issues its 2007 “Judicial Hellholes” report, highlighting the most unfair…
Newsletter
CEI Daily Update
Issues in the News 1. INTERNATIONAL The budget of the United Nations is expected to grow by 25% in one year.